HLF Herbalife Ltd. Common Shares
حول Herbalife Ltd. Common Shares نظرة عامة على الشركة من ويكيبيديا
Herbalife Nutrition Ltd., also called Herbalife International, Inc. or simply Herbalife, is an American multinational multi-level marketing (MLM) corporation that develops and sells dietary supplements.
اقرأ المزيد
Herbalife Nutrition Ltd., also called Herbalife International, Inc. (with a U.S. subsidiary called Herbalife International of America) or simply Herbalife, is an American multinational multi-level marketing (MLM) corporation that develops and sells dietary supplements.
The company was founded by Mark R. Hughes in 1980, and employs an estimated 9,900 people worldwide. The company operates in 95 countries through a network of approximately 4.5 million independent distributors and members. In October 2022, previous CEO Michael O. Johnson was appointed as chairman and interim chief executive officer following the departure of John Agwunobi. The business is incorporated in the Cayman Islands, a tax haven, with its corporate headquarters located in Los Angeles, California.
Herbalife has been accused of fraudulently operating a pyramid scheme, deceiving distributors about the amount of income they could expect to earn and that most of their income would be made from recruiting additional distributors instead of from selling merchandise. The company agreed to "fundamentally restructure" its compensation and other benefits in the United States to include tying distributor rewards to verifiable sales, and pay a $200 million fine as part of a 2016 settlement with the U.S. Federal Trade Commission (FTC) following these accusations.
According to a 2007 research paper, some products sold by Herbalife have caused acute hepatitis.
History
In February 1980, Mark R. Hughes began selling the original Herbalife weight management product from the trunk of his car. Hughes often stated that the genesis of his product and program stemmed from the weight loss concerns of his mother Joanne whose premature death he attributed to an eating disorder and an unhealthy approach to weight loss. His first product was a protein shake designed to help people manage their weight. He structured his company using a direct-selling, multi-level marketing model.
In 1982, Herbalife received complaints from the Food and Drug Administration for claims made about certain products and the inclusion of mandrake, poke root, and food-grade linseed oil in another.
The Department of Justice of Canada filed criminal charges against the company in November 1984 for misleading medical claims in advertisements. As a result of the complaints, the company modified its product claims and reformulated the product.
By 1985, Herbalife was considered the fastest-growing private company in America by Inc. after its sales increased from $386 thousand to $423 million over the previous five years. That same year, the California Attorney General sued the company for making inflated claims about the efficacy of its products. The company suffered as a result of the lawsuit and was forced to lay off nearly 800 employees by May 1985. The company settled the suit for $850,000 without admitting wrongdoing.
In 1986, Herbalife became a publicly traded company on the NASDAQ and rebranded itself as Herbalife International. However, as a result of the negative publicity from the FDA lawsuit, the company posted a $3 million loss that year.
By 1988, the company had expanded its reach to Japan, Spain, New Zealand, Israel, and Mexico, and it increased its worldwide sales to $191 million in 1991.
In 1993, the company underwent a secondary offering of five million shares.
The company launched a line of personal care products in 1995 which included fragrances and facial cleansing products.
The company was sued in civil court by two former distributors in 1997 for withholding earned income.
In 1999, Hughes attempted to take the company private after asserting that Wall Street was undervaluing it. While the board approved the buyout offer, shareholders of the company filed a suit against the company because they believed the share price they were offered was unfair. Hughes eventually abandoned his attempt to buy the company and settled the suit with shareholders. On May 20, 2000, Mark Hughes died at age 44. Following his death, the company was led by Christopher Pair until October 2001.
In March 2026, Herbalife acquired Bioniq, a UK-based personalized supplements company that uses blood biomarker analysis to formulate products, for up to US$150 million.
J.H. Whitney & Company and Golden Gate Capital
In 2002, the company was acquired for US$685 million by J.H. Whitney & Company and Golden Gate Capital. Concurrently, plant sources of ephedrine were removed from Herbalife products in 2002 after several U.S. states banned supplements containing such herbs.
In April 2003, Michael O. Johnson joined Herbalife as CEO following a 17-year career with The Walt Disney Company.
On December 16, 2004, the company had an initial public offering on the NYSE of 14.5 million common shares at $14 per share, netting the owners $1.3 billion.
On May 7, 2014, the company announced that it entered into a deal with Bank of America Merrill Lynch to repurchase $266 million of its stock.
The company announced in November 2016 that Chief Operating Officer Richard Goudis would take over the position of CEO in June 2017 and Johnson would transition to Executive Chairman.
In August 2017, the company announced that it would repurchase up to $600 million of its stock.
On April 25, 2018, Herbalife announced that it had changed its name from Herbalife Ltd. to Herbalife Nutrition Ltd. The company also announced that its shareholders had approved a two-for-one stock split.
In January 2019, Herbalife announced that it was replacing Goudis after learning of comments he had made before taking over as CEO that were "contrary to the company’s expense-related policies and business practices” and inconsistent with the company's standards and culture". Former CEO Johnson subsequently took over the role on an interim basis.
In March 2020, John Agwunobi was appointed Chief Executive Officer. Agwunobi departed from Herbalife in October 2022 and Michael O. Johnson was appointed Chairman and interim Chief Executive Officer.
In May 2025, Stephan Gratziani was appointed Chief Executive Officer, becoming the first distributor since founder Mark Hughes to lead the company. Michael O. Johnson transitioned in the position of Executive Chairman.
Products
Herbalife Nutrition's products include weight-loss and protein shakes, as well as protein bars, teas, aloes, vitamins, and sports hydration, energy, and personal care products. The company's original product is the Formula 1 protein shake, a soy-based meal-replacement shake. The product debuted in 1980 and, as of 2015, was the company's best selling product accounting for nearly 30% of total sales.
Herbalife's products are produced at the company's five manufacturing facilities in the U.S. and China, as well as by third-party manufacturing partners. The company's production process is based on a "seed to feed" strategy, which the company initiated in the 2010s that allows it to trace where the ingredients in its nutritional products originated. Since 2013, the company has operated a botanical extraction facility in Changsha, Hunan Province, China. The facility produces botanical extracts, including teas, guarana, chamomile, broccoli, and bilberry, for use in many of the company's products. Before extracts are processed, they undergo a botanical identification program and are tested several times throughout the production process. The processed raw materials from the extraction facility are used at all of the company's branded manufacturing facilities as well as by its partners. As of 2015, 58% of the company's nutrition products were manufactured at Herbalife-owned facilities.
In China, the company's manufacturing sites are located in Suzhou and Nanjing. In the U.S., the company has manufacturing facilities in Lake Forest, California, and Winston-Salem, North Carolina.
Herbalife's claims of health benefits from its products have met scrutiny from the medical community, consumers, and government agencies.
In 2008, Herbalife was sued after laboratory tests indicated that levels of lead in several Herbalife products were in excess of California state law and could lead to liver problems over an extended period of time. The company commissioned its own lab testing and found that those products did not contain high enough amounts of lead to require special labeling.
Business model
Herbalife Nutrition is a multi-level marketing company. A 2010 article in the Los Angeles Business Journal claimed that Herbalife Nutrition was one of the most profitable companies in Los Angeles County and directly benefited from its business model.
As a result of the 2016 FTC settlement, the company is required to prove that at least 80 percent of its sales are made to individuals outside of its distributor network. Distributors are responsible for providing receipts for sales and proving they have legitimate customers. The settlement also required that distributors are only able to earn one-third of their rewards based on recruitment. In the U.S., the company now differentiates between individuals who join as a member to buy discounted products and those who join as a distributor seeking a business opportunity. Discount buyers are unable to earn rewards or sell products. Herbalife Nutrition is also required to have its practices monitored by an outside party for seven years to ensure compliance.
In the past, company management considered the number and retention of distributors a key parameter and tracked it closely in financial reports. By January of each year, sales leaders are required to requalify. In February of each year, individuals who did not satisfy the sales leader qualification requirements during the preceding 12 months are removed from that rank. For the latest 12-month requalification period ending January 2019, approximately 67.9 percent of the eligible sales leaders requalified.
In a California class action suit (Minton v. Herbalife International, et al.) filed on February 17, 2005, the plaintiff challenged "the marketing practices of certain Herbalife International independent distributors under various state laws". In a West Virginia class action suit (Mey v. Herbalife International, Inc., et al.) filed on July 16, 2003, the plaintiffs alleged that some of Herbalife International's distributors used pre-recorded telephone messages and autodialers to contact prospective customers in violation of the Telephone Consumer Protection Act. The case was resolved with Herbalife and its distributors paying $7 million into a fund for class members part of the suit.
Liver disease inquiries
Hospitals in Israel, Spain, Switzerland, Iceland, Argentina, and the United States have reported liver damage in a number of patients who used Herbalife products.
In 2004, Israel's Health Minister began an investigation into Herbalife's products after four persons using Herbalife's products were found to have liver problems. The company was criticized for the presence of lead and other heavy metals in some of its products, with comfrey specifically flagged for its association with liver toxicity. The products were sent to Bio-Medical Research Design LTD (B.R.D), to a private U.S. laboratory, and to Israel's Forensic research laboratory. A study of the cases funded by the Israeli Ministry of Health concluded that there was a causative relationship. Herbalife's SEC 10-Q filings stated that the Israeli Ministry of Health did not establish a causal relationship between the product and liver ailments. In 2009, an Israeli woman sued Herbalife International and Herbalife Israel, claiming that her liver damage resulted from the use of Herbalife products.
Scientific studies in 2007 by doctors at the University Hospital of Bern in Switzerland and the Liver Unit of the Hadassah-Hebrew University Medical Center in Israel found an association between consumption of Herbalife products and hepatitis. In response, the Spanish Ministry of Health issued an alert asking for caution in consuming Herbalife products. Herbalife stated they were cooperating fully with Spanish authorities, and after investigation, the agency determined no action was required and removed the alert.
In January 2009, the Scientific Committee of the Spanish Agency for Food Safety and Nutrition (AESAN) reached the same conclusion. After reviewing cases implicating Herbalife products in Spain, Switzerland, Israel, Finland, France, Italy, Iceland and Portugal, the 12-member scientific panel issued a report concluding: "The analyses of these cases and information regarding their circumstances have not allowed us to establish a causal relationship" between liver anomalies and Herbalife's dietary supplements. The panel attributed the cases to metabolic changes from overzealous and unsupervised dieting.
A July 2013 peer-reviewed study published in the World Journal of Hepatology reexamined known cases of hepatotoxicity that had previously been linked to consumption of Herbalife products and concluded that using "the liver specific Council for International Organizations of Medical Sciences scale, causality was probable in 1 case, unlikely and excluded in the other cases. Thus, causality levels were much lower than hitherto proposed". In a separate review published less than a year earlier, the same author described the relationship between Herbalife products and reported hepatotoxicity cases as "highly probable".
In 2019, the Journal of Clinical and Experimental Hepatology published a paper titled "Slimming to the Death: Herbalife-Associated Fatal Acute Liver Failure-Heavy Metals, Toxic Compounds, Bacterial Contaminants and Psychotropic Agents in Products Sold in India". This paper examined the connection between Herbalife slimming products and a case of fatal acute liver failure in one patient in India. In December 2020, the journal retracted the aforementioned article, contrary to the COPE guidelines, which advise that the original paper should remain available but prominently marked as retracted. According to one of the co-authors of the paper, this retraction happened because Herbalife engaged DSK Legal, a New Delhi–based law firm, to consistently issue legal threats to the journal's editor-in-chief.
Pyramid scheme allegations
Critics of the company's structure have contended that it has operated as a pyramid scheme. They have also argued that the company does not sufficiently work to curb abuses by individual distributors, though Herbalife Nutrition has consistently denied the allegations.
A 2004 settlement resolved a class-action suit on behalf of 8,700 former and current distributors who accused the company and distributors of "essentially running a pyramid scheme". A total of $6 million was to be paid out, with defendants not admitting guilt.
In November 2011, the Commercial Court in Brussels, Belgium, ruled that Herbalife was an illegal pyramid scheme. The company filed an appeal on March 8, 2012. On December 3, 2013, a Belgian appeals court found for Herbalife, reversing the lower court's finding.
On May 1, 2012, a short seller, David Einhorn, asked questions about the company's business and sales models during the Q1 earnings call, setting off suspicions that Einhorn had a short position. These suspicions were proved correct in January 2013 when at an investor meeting Einhorn revealed that he had profited through a short position against the company. Einhorn said the short had been closed before the end of 2012.
Bill Ackman
On December 20, 2012, Bill Ackman (of Pershing Square Capital) presented a series of arguments outlining why his firm believed that Herbalife operated a "sophisticated pyramid scheme" and contended that its stock would hit zero. Ackman alleged after a year-long investigation that the majority of distributors lose money, that the chance of making the testimonial-implied headline income is approximately one in five thousand, and that the company materially overstates its distributors' retail sales and understates their recruiting rewards.
According to a number of financial commentators, Ackman bet roughly $1 billion against the company; soon after remarks to the press, the price of the stock decreased such that Ackman would have made $300 million if he had closed his short position then. In March 2015, federal prosecutors and the FBI revealed that they were investigating whether or not individuals paid by Ackman and otherwise had made false statements about Herbalife's business model to regulators and others in order to lower the company's stock price and influence authorities to conduct an investigation.
In November 2017, Ackman closed out his short position after Herbalife shares increased by 51 percent over the year, and replaced it with a less aggressive put option. In March 2018, The Wall Street Journal reported that Ackman had "largely exited" his bet against the company, while others reported that the bet against Herbalife had cost his company hundreds of millions of dollars and damaged the confidence of investors in his hedge fund.
FTC investigation
Based on information from a Freedom of Information Act (FOIA) request, the New York Post reported on February 4, 2013, that Herbalife was subject to a pending probe from the Federal Trade Commission (FTC). The FTC released 729 pages containing 192 complaints received over a seven-year period in regards to the New York Post's FOIA request. The FTC stated that the wording in its response to the FOIA request was incorrect; the FTC could not confirm or deny an investigation into Herbalife.
In March 2014, the FTC opened an investigation into Herbalife in response to calls from consumer groups and members in both houses of the United States Congress. Herbalife responded to the probe by saying it "welcomes the inquiry given the tremendous amount of misinformation in the marketplace, and will cooperate fully with the FTC. We are confident that Herbalife is in compliance with all applicable laws and regulations". However, in the press conference, Herbalife was declared not necessarily not a pyramid scheme.
In July 2016, Herbalife agreed to modify its business model and pay $200 million in a settlement with the FTC. Partial refund checks were mailed to roughly 350,000 Herbalife distributors in January 2017. The FTC said in a press release about the settlement "it's virtually impossible to make money selling Herbalife products."
The lawsuit alleged Herbalife deceived consumers into believing they could earn substantial income from the business opportunity or big money from the retail sale of the company's products. In addition, the complaint charged that one of the fundamental principles of Herbalife's business model—incentivizing distributors to buy products and to recruit others to join and buy products so they could advance in the company's marketing program, rather than in response to actual consumer demand—is an unfair practice in violation of the FTC Act.
The company remained under investigation as of early 2019 both by the United States Department of Justice (DOJ) and the U.S. Securities and Exchange Commission (SEC) for corruption in China.
On September 27, 2019, the SEC announced Herbalife agreed to pay $20 million to settle charges of making false and misleading statements about its business model and operations in China between 2012 and 2018. The company did not admit or deny the charges but agreed to the settlement terms.
U.S. Department of Justice investigation of bribery in China
In 2019, the DOJ charged two of Herbalife's employees with conspiracy in violation of the Foreign Corrupt Practices Act (FCPA). They were accused of bribing Chinese officials to procure sales permits and influence an investigation into Herbalife. They were also accused of offering bribes to China Economic Net to influence media coverage. In response, Herbalife committed $40 million to resolve the issues, and began negotiations with both the DOJ and SEC. In August 2020, Herbalife agreed to pay $123 million to the DOJ and the U.S. Securities and Exchange Commission.
Sports sponsorships
Herbalife has sponsored France's national volleyball team and the Major League Soccer club LA Galaxy since 2007 and has sponsored Cristiano Ronaldo since 2013. They sponsored FC Barcelona and Lionel Messi between 2010 and 2013. Herbalife has also sponsored the basketball club Herbalife Gran Canaria since 2012. In July 2020, Herbalife also sponsored the Guangzhou Charge of the Overwatch League. In addition to these team and player sponsorships, Turkish Women's Basketball Super League has been named 'Herbalife Nutrition Women's Basketball Super League' for three years starting the 2019-2020 regular season.
During the 2020 Summer Olympics, Herbalife Nutrition was a sponsor of the Olympic Committee of Israel and the Indian Olympic Association. In 2023, Herbalife became a sponsor of the Indian Premier League.
In 2023, the company became the main shirt sponsor of the Western Sydney Wanderers FC women's football team.
Herbalife has also sponsored Indian cricket star and former captain Virat Kohli since 2011-2025. They have also sponsored other Indian athletes including Smriti Mandhana, Manika Batra, Lakshya Sen, and Palak Kohli.
Media
In April 2016, a documentary directed by Ted Braun, titled Betting on Zero, premiered at the Tribeca Film Festival. It explored the allegation from Bill Ackman that Herbalife was a pyramid scheme and personal stories of its distributors who lost their life savings. Hilary Rosen, a Democratic lobbyist and an adviser to Herbalife, questioned Tribeca's credibility after claiming that the film was "bought and paid" for by Ackman "to make good on his stock bet".
In 2016, a Last Week Tonight with John Oliver segment on multi-level marketing focused on Herbalife; it strongly condemned the company for its structure resembling a pyramid scheme and cited the FTC report, which implied the company had been operating illegitimately. Oliver criticized Herbalife for its exploitation of Latino communities, and overstatement of its products' health benefits. One reviewer wrote that it appeared to be largely based on Betting on Zero, and caused no immediate change in Herbalife's stock prices.
The 2018 book When The Wolves Bite: Two Billionaires, One Company, and an Epic Wall Street Battle by Scott Wapner discusses Ackman's short of the company and his battle with Carl Icahn. In the book, Wapner characterizes Ackman's decision to bet against Herbalife as dangerous, because it anticipated that the government would shut Herbalife down.
المصدر: ويكيبيديا (الإنجليزية), CC BY-SA 4.0 · عرض على ويكيبيديا ↗
HLF لقطة سريعة للسهم السعر، القيمة السوقية، مكرر الربحية (P/E)، ربحية السهم (EPS)، العائد على حقوق الملكية (ROE)، نسبة الدين إلى حقوق الملكية، نطاق 52 أسبوعًا
HLF مخطط سعر السهم OHLCV يومي مع مؤشرات فنية — تحريك وتكبير وتخصيص عرضك
أداء 10 سنوات اتجاهات الإيرادات وصافي الدخل والهوامش وربحية السهم
التقييم نسب مكرر الربحية (P/E)، مكرر المبيعات (P/S)، مكرر القيمة الدفترية (P/B)، EV/EBITDA — هل السهم مرتفع السعر أم رخيص؟
الربحية هامش الربح الإجمالي والتشغيلي والصافي؛ العائد على حقوق الملكية (ROE)، العائد على الأصول (ROA)، العائد على رأس المال المستثمر (ROIC)
الصحة المالية الديون، السيولة، الملاءة المالية — قوة الميزانية العمومية
النمو نمو الإيرادات وربحية السهم وصافي الدخل: مقارنة بالعام السابق (YoY)، متوسط النمو السنوي المركب لـ 3 سنوات (3Y CAGR)، متوسط النمو السنوي المركب لـ 5 سنوات (5Y CAGR)
كفاءة رأس المال معدل دوران الأصول، معدل دوران المخزون، معدل دوران المستحقات
التوزيعات العائد، نسبة التوزيع، تاريخ توزيع الأرباح، معدل النمو السنوي المركب لمدة 5 سنوات
| تاريخ الاستحقاق | المبلغ |
|---|---|
| 28 فبراير، 2014 | $0,1500 |
| 7 نوفمبر، 2013 | $0,1500 |
| 9 أغسطس، 2013 | $0,1500 |
| 10 مايو، 2013 | $0,1500 |
| 1 مارس، 2013 | $0,1500 |
| 9 نوفمبر، 2012 | $0,1500 |
| 10 أغسطس، 2012 | $0,1500 |
| 11 مايو، 2012 | $0,1500 |
| 5 مارس، 2012 | $0,1500 |
| 9 نوفمبر، 2011 | $0,1000 |
| 11 أغسطس، 2011 | $0,1000 |
| 20 مايو، 2011 | $0,0500 |
| 4 مارس، 2011 | $0,0625 |
| 10 نوفمبر، 2010 | $0,0625 |
| 10 أغسطس، 2010 | $0,0625 |
| 6 مايو، 2010 | $0,0500 |
| 26 فبراير، 2010 | $0,0500 |
| 23 نوفمبر، 2009 | $0,0500 |
| 26 أغسطس، 2009 | $0,0500 |
| 20 مايو، 2009 | $0,0500 |
HLF توافق الآراء التحليلي آراء المحللين الصعودية والهبوطية، السعر المستهدف لمدة 12 شهرًا، الصعود
- شراء قوي 3 37,5%
- شراء 3 37,5%
- احتفاظ 1 12,5%
- بيع 1 12,5%
- بيع قوي 0 0,0%
السعر المستهدف لمدة 12 شهرًا
3 محللين · 2026-08-15سجل الأرباح ربحية السهم الفعلية مقابل التقديرات، نسبة المفاجأة %، معدل التجاوز، تاريخ الأرباح التالي
| الفترة | EPS Actual | EPS المتوقع | المفاجأة |
|---|---|---|---|
| 30 يونيو، 2026 | $0.51 | $0.54 | -0.03% |
| 31 مارس، 2026 | $0.64 | $0.58 | 0.06% |
| 31 ديسمبر، 2025 | $0.45 | $0.43 | 0.02% |
| 30 سبتمبر، 2025 | $0.50 | $0.47 | 0.03% |
| 30 يونيو، 2025 | $0.59 | $0.39 | 0.20% |
| 31 مارس، 2025 | $0.59 | $0.37 | 0.22% |
الأساسيات الكاملة جميع المقاييس حسب السنة — قائمة الدخل، الميزانية العمومية، التدفق النقدي
قائمة الدخل 16
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.04B | $4.99B | $5.06B | $5.20B | $5.80B | $5.54B | $4.88B | $4.89B | $4.43B | $4.49B | $4.47B | $4.96B | |
| Cost of Revenue | $1.11B | $1.10B | $1.19B | $1.17B | $1.24B | $1.15B | $958M | $919M | $849M | $855M | $856M | $983M | |
| Gross Profit | $3.92B | $3.89B | $3.87B | $4.03B | $4.56B | $4.39B | $3.92B | $3.97B | $3.58B | $3.63B | $3.61B | $3.98B | |
| SG&A Expense | $1.66B | $1.73B | $1.70B | $1.81B | $2.01B | $2.08B | $1.94B | $1.96B | $1.76B | $1.97B | $1.78B | $1.99B | |
| Operating Income | $481M | $386M | $356M | $545M | $734M | $641M | $568M | $683M | $617M | $458M | $584M | $514M | |
| Interest Expense | $214M | $218M | $166M | $139M | $153M | $133M | $153M | $181M | $161M | $99M | $100M | $92M | |
| Interest Income | · | · | · | · | · | · | · | · | $14M | $6M | $6M | $12M | |
| Other Non-op | $0 | $-10M | $1M | $13M | $-25M | $0 | $-16M | $-57M | $400.0K | · | $-2M | $-13M | |
| Pretax Income | $275M | $169M | $203M | $425M | $561M | $516M | $451M | $464M | $471M | $365M | $486M | $421M | |
| Income Tax | $47M | $-85M | $61M | $104M | $114M | $144M | $140M | $168M | $257M | $105M | $147M | $113M | |
| Net Income | $228M | $254M | $142M | $321M | $447M | $373M | $311M | $297M | $214M | $260M | $339M | $309M | |
| EPS (Basic) | $2.22 | $2.53 | $1.44 | $3.26 | $4.22 | $2.83 | $2.26 | $2.12 | $1.35 | $1.57 | $4.11 | $3.58 | |
| EPS (Diluted) | $2.20 | $2.50 | $1.42 | $3.23 | $4.13 | $2.77 | $2.20 | $1.98 | $1.29 | $1.51 | $3.97 | $3.40 | |
| Shares (Basic) | 102,800,000 | 100,600,000 | 99,000,000 | 98,500,000 | 105,900,000 | 131,500,000 | 137,400,000 | 140,200,000 | 158,500,000 | 166,100,000 | 82,600,000 | 86,300,000 | |
| Shares (Diluted) | 103,600,000 | 101,600,000 | 100,200,000 | 99,500,000 | 108,300,000 | 134,500,000 | 141,600,000 | 149,500,000 | 165,700,000 | 172,200,000 | 85,300,000 | 90,800,000 | |
| EBITDA | $481M | $386M | $356M | $545M | $734M | $641M | $568M | $683M | $617M | $458M | $584M | $514M |
الميزانية العمومية 28
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $353M | $415M | $575M | $508M | $602M | $1.05B | $839M | $1.20B | $1.28B | $844M | $890M | $645M | |
| Receivables | $92M | $69M | $81M | $71M | $67M | $83M | $80M | $70M | $93M | $70M | $70M | $84M | |
| Inventory | $512M | $475M | $505M | $581M | $576M | $501M | $436M | $382M | $341M | $371M | $332M | $378M | |
| Prepaid Expense | $188M | $184M | $238M | $197M | $188M | $146M | $133M | $154M | $147M | $177M | $161M | $186M | |
| Current Assets | $1.14B | $1.14B | $1.40B | $1.36B | $1.43B | $1.78B | $1.49B | $1.80B | $1.86B | $1.46B | $1.57B | $1.39B | |
| PP&E (Net) | $448M | $460M | $506M | $486M | $442M | $390M | $372M | $360M | $378M | $378M | $339M | $367M | |
| PP&E (Gross) | $1.51B | $1.48B | $1.52B | $1.52B | $1.46B | $1.32B | $1.22B | $1.13B | $1.08B | $982M | $877M | $850M | |
| Accum. Depreciation | $1.06B | $1.02B | $1.01B | $1.03B | $1.02B | $934M | $845M | $765M | $703M | $604M | $537M | $483M | |
| Goodwill | $100M | $88M | $95M | $93M | $95M | $100M | $92M | $93M | $97M | $90M | $92M | $102M | |
| Intangibles | $315M | $312M | $314M | $316M | $317M | $313M | $310M | $310M | $310M | $310M | $310M | $310M | |
| Other Non-current Assets | $145M | $140M | $129M | $274M | $313M | $274M | $228M | $222M | $250M | $325M | $141M | $155M | |
| Total Assets | $2.79B | $2.73B | $2.81B | $2.73B | $2.82B | $3.08B | $2.68B | $2.79B | $2.90B | $2.57B | $2.48B | $2.35B | |
| Accounts Payable | $100M | $70M | $84M | $90M | $92M | $89M | $82M | $81M | $68M | $66M | $71M | $72M | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | $237M | $229M | $252M | |
| Current Liabilities | $1.01B | $1.23B | $1.28B | $977M | $1.08B | $1.13B | $964M | $1.59B | $907M | $792M | $1.02B | $875M | |
| Capital Leases | $156M | $170M | $168M | $192M | $201M | $207M | $170M | · | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | $39M | $21M | $8M | $8M | $15M | $400.0K | $15M | |
| Other Non-current Liabilities | $155M | $153M | $172M | $166M | $196M | $193M | $155M | $150M | $157M | $139M | $70M | $65M | |
| Total Liabilities | $3.30B | $3.53B | $3.87B | $4.00B | $4.21B | $3.93B | $3.07B | $3.51B | $3.23B | $2.37B | $2.53B | $2.69B | |
| Long-term Debt | $1.99B | $2.26B | $2.56B | $2.69B | $2.76B | $2.43B | $1.80B | $2.45B | $2.27B | $1.45B | $1.62B | $1.79B | |
| Total Debt | $1.99B | $2.26B | $2.56B | $2.69B | $2.76B | $2.43B | $1.80B | $2.45B | $2.27B | $1.45B | $1.62B | $1.81B | |
| Common Stock | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | |
| Retained Earnings | $-580M | $-808M | $-1.06B | $-1.20B | $-1.17B | $-687M | $-215M | $-526M | $-248M | $-66M | $-326M | $-665M | |
| Treasury Stock | · | · | · | $0 | $329M | $329M | $329M | $329M | $329M | · | · | · | |
| AOCI | $-252M | $-271M | $-232M | $-250M | $-212M | $-182M | $-212M | $-210M | $-165M | $-205M | $-166M | $-78M | |
| Stockholders' Equity | $-515M | $-801M | $-1.06B | $-1.27B | $-1.39B | $-856M | $-390M | $-723M | $-335M | $196M | $-54M | $-334M | |
| Liabilities + Equity | $2.79B | $2.73B | $2.81B | $2.73B | $2.82B | $3.08B | $2.68B | $2.79B | $2.90B | $2.57B | $2.48B | $2.35B | |
| Shares Outstanding | 103,300,000 | 101,200,000 | 99,200,000 | 97,900,000 | 100,800,000 | 120,100,000 | 137,400,000 | 142,800,000 | 164,700,000 | 186,300,000 | 92,700,000 | 92,200,000 |
التدفق النقدي 16
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $121M | $121M | $113M | $115M | $108M | $100M | $98M | $100M | $100M | $98M | $98M | $93M | |
| Stock-based Comp | $44M | $50M | $48M | $44M | $54M | $51M | $39M | $36M | $42M | $40M | $45M | $46M | |
| Deferred Tax | $-64M | $-230M | $-41M | $-30M | $-33M | $2M | $15M | $-8M | $98M | $-36M | $-38M | $-85M | |
| Amort. of Intangibles | · | · | · | · | · | · | · | · | · | · | · | $300.0K | |
| Restructuring | $7M | $69M | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $333M | $285M | $358M | $352M | $460M | $629M | $458M | $648M | $591M | $367M | $629M | $511M | |
| CapEx | $80M | $122M | $135M | $156M | $151M | $112M | $106M | $84M | $96M | $143M | $79M | $174M | |
| Investing Cash Flow | $-109M | $-85M | $-135M | $-156M | $-156M | $-123M | $-108M | $-84M | $-95M | $-142M | · | · | |
| Stock Repurchased | $8M | $8M | $11M | $147M | $1.01B | $924M | $17M | $750M | $844M | $13M | $17M | $1.29B | |
| Net Stock Activity | $-8M | $-8M | $-11M | $-147M | $-1.01B | $-924M | $-17M | $-750M | $-844M | $-13M | $-17M | $-1.29B | |
| Dividends Paid | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $30M | |
| Financing Cash Flow | $-296M | $-335M | $-148M | $-265M | $-729M | $-321M | $-713M | $-593M | $-85M | $-252M | · | · | |
| Net Change in Cash | $-63M | $-157M | $79M | $-94M | $-444M | $206M | $-368M | $-80M | $439M | $-48M | $244M | $-328M | |
| Taxes Paid | $117M | $132M | $121M | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $253M | $163M | $222M | $196M | $309M | $517M | $351M | $564M | $495M | $224M | $550M | $338M | |
| Levered FCF | $75M | $-164M | $106M | $91M | $187M | $421M | $246M | $449M | $422M | $153M | $480M | · |
الربحية 8
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 77.9% | 77.9% | 76.5% | 77.5% | 78.6% | 79.2% | 80.4% | 81.2% | 80.8% | 81.0% | 80.8% | 80.2% | |
| Operating Margin | 9.6% | 7.7% | 7.0% | 10.5% | 12.7% | 11.6% | 11.7% | 14.0% | 13.9% | 10.2% | 13.1% | 10.4% | |
| Net Margin | 4.5% | 5.1% | 2.8% | 6.2% | 7.7% | 6.7% | 6.4% | 6.1% | 4.8% | 5.8% | 7.6% | 6.2% | |
| Pretax Margin | 5.5% | 3.4% | 4.0% | 8.2% | 9.7% | 9.3% | 9.3% | 9.5% | 10.6% | 8.1% | 10.9% | 8.5% | |
| EBITDA Margin | 9.6% | 7.7% | 7.0% | 10.5% | 12.7% | 11.6% | 11.7% | 14.0% | 13.9% | 10.2% | 13.1% | 10.4% | |
| ROA | 8.3% | 9.2% | 5.1% | 11.6% | 15.2% | 13.0% | 11.4% | 10.4% | 7.8% | 10.3% | 14.0% | 12.7% | |
| ROE | -34.7% | -27.7% | -13.1% | -24.4% | -32.8% | -42.1% | -72.5% | -40.0% | -309.1% | 364.2% | -174.8% | 284.5% | |
| ROIC | 27.0% | 39.7% | 16.6% | 28.9% | 42.7% | 29.4% | 27.7% | 25.2% | 14.5% | 19.9% | 25.9% | 25.5% |
السيولة والملاءة 5
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.1 | 0.9 | 1.1 | 1.4 | 1.3 | 1.6 | 1.5 | 1.1 | 2.1 | 1.8 | 1.5 | 1.6 | |
| Quick Ratio | 0.4 | 0.4 | 0.5 | 0.6 | 0.6 | 1.0 | 1.0 | 0.8 | 1.5 | 1.2 | 0.9 | 0.8 | |
| Debt / Equity | -3.9 | -2.8 | -2.4 | -2.1 | -2.0 | -2.8 | -4.6 | -3.4 | -6.8 | 7.4 | -30.3 | -5.4 | |
| LT Debt / Equity | -3.8 | -2.5 | -2.1 | -2.1 | -2.0 | -2.8 | -4.6 | -2.5 | -6.5 | 7.3 | -26.0 | -5.1 | |
| Interest Coverage | 2.2 | 1.8 | 2.1 | 3.9 | 4.8 | 4.8 | 3.7 | 3.8 | 3.8 | 4.6 | 5.8 | · |
الكفاءة 3
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.8 | 1.8 | 1.8 | 1.9 | 2.0 | 1.9 | 1.8 | 1.7 | 1.6 | 1.8 | 1.8 | 2.0 | |
| Inventory Turnover | 2.3 | 2.3 | 2.2 | 2.0 | 2.3 | 2.5 | 2.3 | 2.5 | 2.4 | 2.4 | 2.4 | 2.7 | |
| Receivables Turnover | 62.7 | 66.5 | 66.7 | 75.7 | 77.3 | 68.0 | 64.9 | 59.7 | 54.1 | 64.0 | 58.2 | 53.9 |
معدلات النمو 9
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 0.89% | -1.4% | -2.7% | -10.3% | 4.7% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -1.1% | -4.9% | -3.0% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -1.9% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -12.0% | 76.1% | -56.0% | -21.8% | 49.1% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -12.0% | -15.4% | -20.0% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -4.5% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -10.2% | 78.8% | -55.7% | -28.1% | 20.0% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -10.8% | -17.2% | -27.5% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -9.3% | · | · | · | · | · | · | · | · | · | · | · |
التقييم (آخر 12 شهرًا) 16
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $5.04B | $4.99B | $5.06B | $5.20B | $5.80B | $5.54B | $4.88B | $4.89B | $4.43B | $4.49B | $4.47B | $4.96B | |
| Net Income TTM | $228M | $254M | $142M | $321M | $447M | $373M | $311M | $297M | $214M | $260M | $339M | $309M | |
| Market Cap | $1.33B | $677M | $1.51B | $1.46B | $4.13B | $5.77B | $6.55B | $8.42B | $2.79B | $2.24B | $2.49B | $1.74B | |
| Enterprise Value | $2.97B | $2.52B | $3.50B | $3.64B | $6.29B | $7.15B | $7.51B | $9.67B | $3.78B | $2.84B | $3.22B | $2.90B | |
| P/E | 5.9 | 2.7 | 10.7 | 4.6 | 9.9 | 17.3 | 21.7 | 29.8 | 26.2 | 15.9 | 6.8 | 5.5 | |
| P/S | 0.3 | 0.1 | 0.3 | 0.3 | 0.7 | 1.0 | 1.3 | 1.7 | 0.6 | 0.5 | 0.6 | 0.4 | |
| P/B | -2.6 | -0.8 | -1.4 | -1.2 | -3.0 | -6.7 | -16.8 | -11.6 | -8.3 | 11.4 | -46.5 | -5.2 | |
| P / Cash Flow | 4.0 | 2.4 | 4.2 | 4.1 | 9.0 | 9.2 | 14.3 | 13.0 | 4.7 | 6.1 | 4.0 | 3.4 | |
| P / FCF | 5.3 | 4.1 | 6.8 | 7.4 | 13.4 | 11.2 | 18.6 | 14.9 | 5.6 | 10.0 | 4.5 | 5.1 | |
| EV / EBITDA | 6.2 | 6.5 | 9.8 | 6.7 | 8.6 | 11.2 | 13.2 | 14.2 | 6.1 | 6.2 | 5.5 | 5.7 | |
| EV / FCF | 11.7 | 15.4 | 15.7 | 18.6 | 20.4 | 13.8 | 21.4 | 17.1 | 7.6 | 12.7 | 5.9 | 8.6 | |
| EV / Revenue | 0.6 | 0.5 | 0.7 | 0.7 | 1.1 | 1.3 | 1.5 | 2.0 | 0.9 | 0.6 | 0.7 | 0.6 | |
| Dividend Yield | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 1.8% | |
| Earnings Yield | 17.1% | 37.4% | 9.3% | 21.7% | 10.1% | 5.8% | 4.6% | 3.4% | 3.8% | 6.3% | 14.8% | 18.0% | |
| Payout Ratio | · | · | · | · | · | · | · | 0.00% | 0.00% | 0.00% | 0.00% | 9.8% | |
| Annual Payout | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $30M |
قائمة الدخل 15
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.33B | $1.32B | $1.28B | $1.27B | $1.26B | $1.22B | $1.21B | $1.24B | $1.28B | $1.26B | $1.22B | $1.28B | $1.31B | $1.25B | $1.18B | $1.30B | |
| Cost of Revenue | $296M | $291M | $288M | $284M | $277M | $265M | $268M | $269M | $283M | $285M | $288M | $303M | $302M | $299M | $266M | $285M | |
| Gross Profit | $1.03B | $1.03B | $995M | $990M | $982M | $956M | $940M | $972M | $998M | $979M | $927M | $978M | $1.01B | $954M | $915M | $1.01B | |
| SG&A Expense | $436M | $431M | $337M | $448M | $408M | $400M | $287M | $444M | $502M | $492M | $309M | $455M | $460M | $476M | $437M | $448M | |
| Operating Income | $128M | $138M | $100M | $126M | $133M | $123M | $106M | $127M | $80M | $72M | $56M | $107M | $123M | $70M | $89M | $147M | |
| Interest Expense | $37M | $47M | $58M | $51M | $54M | $52M | $66M | $56M | $58M | $38M | $50M | $38M | $38M | $39M | $43M | $34M | |
| Other Non-op | $-95M | · | $0 | $0 | $0 | · | $0 | $0 | $-10M | · | $0 | $1M | · | · | $13M | $0 | |
| Pretax Income | $-4M | $92M | $50M | $75M | $79M | $71M | $53M | $71M | $12M | $34M | $18M | $69M | $85M | $31M | $64M | $113M | |
| Income Tax | $23M | $30M | $-35M | $32M | $30M | $20M | $-125M | $23M | $8M | $10M | $8M | $26M | $25M | $2M | $10M | $31M | |
| Net Income | $-26M | $62M | $85M | $43M | $49M | $50M | $178M | $47M | $5M | $24M | $10M | $43M | $60M | $29M | $54M | $82M | |
| EPS (Basic) | $-0.25 | $0.60 | $0.82 | $0.42 | $0.48 | $0.50 | $1.77 | $0.47 | $0.05 | $0.24 | $0.11 | $0.43 | $0.60 | $0.30 | $0.56 | $0.84 | |
| EPS (Diluted) | $-0.25 | $0.57 | $0.81 | $0.42 | $0.48 | $0.49 | $1.75 | $0.46 | $0.05 | $0.24 | $0.10 | $0.43 | $0.60 | $0.29 | $0.56 | $0.83 | |
| Shares (Basic) | 104,500,000 | 103,800,000 | -204,700,000 | 103,300,000 | 102,700,000 | 101,500,000 | -200,600,000 | 100,900,000 | 100,600,000 | 99,700,000 | -197,800,000 | 99,200,000 | 99,100,000 | 98,500,000 | -197,600,000 | 98,000,000 | |
| Shares (Diluted) | 104,500,000 | 108,400,000 | -205,900,000 | 104,000,000 | 103,300,000 | 102,200,000 | -202,700,000 | 101,900,000 | 101,700,000 | 100,700,000 | -199,900,000 | 100,400,000 | 99,500,000 | 100,200,000 | -199,700,000 | 98,800,000 | |
| EBITDA | $128M | · | · | $126M | $133M | $123M | · | $127M | $80M | $72M | · | $107M | $123M | $70M | · | $147M |
الميزانية العمومية 26
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $370M | $451M | $353M | $306M | $321M | $329M | $415M | $402M | $374M | $398M | · | $496M | $527M | $454M | · | $532M | |
| Receivables | $116M | $106M | $92M | $98M | $96M | $90M | $69M | $82M | $83M | $88M | · | $80M | $86M | $85M | · | $85M | |
| Inventory | $508M | $495M | $512M | $512M | $513M | $488M | $475M | $515M | $481M | $502M | · | $497M | $525M | $545M | · | $537M | |
| Prepaid Expense | $175M | $200M | $188M | $190M | $173M | $186M | $184M | $245M | $276M | $238M | · | $274M | $233M | $238M | · | $229M | |
| Current Assets | $1.17B | $1.25B | $1.14B | $1.11B | $1.10B | $1.09B | $1.14B | $1.24B | $1.21B | $1.23B | · | $1.35B | $1.37B | $1.32B | · | $1.38B | |
| PP&E (Net) | $412M | $429M | $448M | $457M | $466M | $450M | $460M | $463M | $468M | $511M | $506M | $492M | $486M | $480M | $486M | $468M | |
| PP&E (Gross) | · | · | $1.51B | · | · | · | $1.48B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $1.06B | · | · | · | $1.02B | · | · | · | · | · | · | · | · | · | |
| Goodwill | $126M | $99M | $100M | $101M | $101M | $89M | $88M | $93M | $92M | $94M | · | $93M | $94M | $94M | · | $88M | |
| Intangibles | $333M | $315M | $315M | $316M | $316M | $312M | $312M | $313M | $313M | $314M | · | $314M | $315M | $315M | · | $316M | |
| Other Non-current Assets | $172M | $147M | $145M | $144M | $140M | $141M | $140M | $352M | $327M | $323M | · | $288M | $304M | $274M | · | $269M | |
| Total Assets | $2.86B | $2.88B | $2.79B | $2.70B | $2.74B | $2.68B | $2.73B | $2.65B | $2.60B | $2.65B | · | $2.72B | $2.77B | $2.69B | · | $2.73B | |
| Accounts Payable | $101M | $88M | $100M | $88M | $92M | $85M | $70M | $87M | $81M | $90M | · | $78M | $89M | $68M | · | $84M | |
| Current Liabilities | $974M | $1.02B | $1.01B | $1000M | $1.09B | $1.13B | $1.23B | $1.28B | $976M | $945M | · | $1.17B | $1.24B | $1.23B | · | $986M | |
| Capital Leases | $152M | $155M | $156M | $157M | $165M | $167M | $170M | $167M | $173M | $164M | · | $174M | $184M | $186M | · | $188M | |
| Other Non-current Liabilities | $195M | $150M | $155M | $149M | $157M | $149M | $153M | $178M | $169M | $170M | · | $170M | $170M | $161M | · | $189M | |
| Total Liabilities | $3.32B | $3.31B | $3.30B | $3.30B | $3.39B | $3.42B | $3.53B | $3.61B | $3.64B | $3.68B | · | $3.83B | $3.92B | $3.91B | · | $4.09B | |
| Long-term Debt | $2.02B | $1.99B | $1.99B | $2.02B | $2.14B | $2.19B | $2.26B | $2.26B | $2.34B | $2.41B | · | $2.55B | $2.62B | $2.63B | · | $2.75B | |
| Total Debt | $2.02B | · | · | $2.02B | $2.14B | $2.19B | · | $2.26B | $2.34B | $2.41B | · | $2.55B | $2.62B | $2.63B | · | $2.75B | |
| Common Stock | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | · | $100.0K | $100.0K | $100.0K | · | $100.0K | |
| Retained Earnings | $-544M | $-518M | $-580M | $-665M | $-708M | $-758M | $-808M | $-986M | $-1.03B | $-1.04B | · | $-1.07B | $-1.12B | $-1.18B | · | $-1.26B | |
| Treasury Stock | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| AOCI | $-265M | $-258M | $-252M | $-252M | $-247M | $-266M | $-271M | $-235M | $-257M | $-243M | · | $-253M | $-238M | $-239M | · | $-284M | |
| Stockholders' Equity | $-474M | $-442M | $-515M | $-612M | $-660M | $-736M | $-801M | $-954M | $-1.04B | $-1.04B | · | $-1.10B | $-1.15B | $-1.22B | $-1.27B | $-1.36B | |
| Liabilities + Equity | $2.86B | $2.88B | $2.79B | $2.70B | $2.74B | $2.68B | $2.73B | $2.65B | $2.60B | $2.65B | · | $2.72B | $2.77B | $2.69B | · | $2.73B | |
| Shares Outstanding | 104,800,000 | 103,400,000 | 103,300,000 | 103,200,000 | 103,100,000 | 101,600,000 | 101,200,000 | 100,700,000 | 100,700,000 | 99,800,000 | 99,200,000 | 99,000,000 | 98,900,000 | 98,700,000 | 97,900,000 | 97,800,000 |
التدفق النقدي 13
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $31M | $29M | $29M | $31M | $30M | $31M | $29M | $31M | $33M | $29M | $28M | $28M | $29M | $28M | $28M | $29M | |
| Stock-based Comp | $10M | $11M | $11M | $11M | $10M | $12M | $13M | $13M | $12M | $12M | $12M | $14M | $11M | $11M | $7M | $11M | |
| Deferred Tax | $-14M | $300.0K | $-70M | $28M | $-10M | $-13M | $-177M | $-25M | $-15M | $-12M | $-15M | $-18M | $-17M | $9M | $-18M | $-19M | |
| Restructuring | $0 | $0 | $2M | $800.0K | $700.0K | $3M | $900.0K | $3M | $49M | $17M | · | · | · | · | · | · | |
| Operating Cash Flow | $33M | $114M | $98M | $139M | $96M | $200.0K | $70M | $100M | $102M | $14M | $96M | $80M | $136M | $46M | $54M | $70M | |
| CapEx | $11M | $11M | $18M | $21M | $23M | $18M | $26M | $27M | $36M | $33M | $35M | $31M | $38M | $30M | $43M | $38M | |
| Investing Cash Flow | $-22M | $-11M | $-19M | $-21M | $-51M | $-19M | $-26M | $10M | $-36M | $-33M | $-35M | $-31M | $-38M | $-30M | $-43M | $-38M | |
| Stock Repurchased | $9M | $700.0K | $100.0K | $1M | $5M | $2M | $3M | $0 | $3M | $2M | $1M | $300.0K | $700.0K | $9M | $100.0K | $100.0K | |
| Net Stock Activity | · | · | · | · | · | $-2M | · | · | · | $-2M | · | · | · | $-9M | · | · | |
| Financing Cash Flow | $-83M | $2M | $-33M | $-130M | $-60M | $-72M | $-9M | $-86M | $-82M | $-158M | $8M | $-71M | $-9M | $-76M | $-50M | $-56M | |
| Net Change in Cash | $-80M | $98M | $47M | $-16M | $-7M | $-87M | $20M | $29M | $-23M | $-183M | $80M | $-31M | $86M | $-54M | $-24M | $-49M | |
| Free Cash Flow | · | · | · | · | · | $-18M | · | · | · | $-19M | · | · | · | $16M | · | · | |
| Levered FCF | · | · | · | · | · | $-55M | · | · | · | $-46M | · | · | · | $-21M | · | · |
الربحية 8
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 77.7% | · | · | 77.7% | 78.0% | 78.3% | · | 78.3% | 77.9% | 77.5% | · | 76.3% | 77.0% | 76.1% | · | 78.0% | |
| Operating Margin | 9.7% | · | · | 9.9% | 10.5% | 10.1% | · | 10.2% | 6.3% | 5.7% | · | 8.3% | 9.4% | 5.6% | · | 11.4% | |
| Net Margin | -2.0% | · | · | 3.4% | 3.9% | 4.1% | · | 3.8% | 0.37% | 1.9% | · | 3.3% | 4.6% | 2.3% | · | 6.3% | |
| Pretax Margin | -0.28% | · | · | 5.9% | 6.3% | 5.8% | · | 5.7% | 0.95% | 2.7% | · | 5.4% | 6.5% | 2.5% | · | 8.7% | |
| EBITDA Margin | 9.7% | · | · | 9.9% | 10.5% | 10.1% | · | 10.2% | 6.3% | 5.7% | · | 8.3% | 9.4% | 5.6% | · | 11.4% | |
| ROA | -0.94% | · | · | 1.6% | 1.8% | 1.9% | · | 1.8% | 0.17% | 0.91% | · | 1.6% | 2.1% | 1.1% | · | 2.9% | |
| ROE | 4.6% | · | · | -5.5% | -5.8% | -5.7% | · | -4.6% | -0.43% | -2.1% | · | -3.5% | -4.7% | -2.2% | · | -6.1% | |
| ROIC | 59.6% | · | · | 5.2% | 5.6% | 6.0% | · | 6.5% | 2.4% | 3.8% | · | 4.6% | 5.9% | 4.7% | · | 7.7% |
السيولة والملاءة 5
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.2 | · | · | 1.1 | 1.0 | 1.0 | · | 1.0 | 1.2 | 1.3 | · | 1.2 | 1.1 | 1.1 | · | 1.4 | |
| Quick Ratio | 0.5 | · | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.4 | · | 0.6 | |
| Debt / Equity | -4.2 | · | · | -3.3 | -3.2 | -3.0 | · | -2.4 | -2.3 | -2.3 | · | -2.3 | -2.3 | -2.2 | · | -2.0 | |
| LT Debt / Equity | -4.2 | · | · | -3.3 | -3.0 | -2.7 | · | -2.1 | -2.2 | -2.3 | · | -2.1 | -2.0 | -1.9 | · | -2.0 | |
| Interest Coverage | 3.4 | · | · | 2.5 | 2.5 | 2.4 | · | 2.2 | 1.4 | 1.9 | · | 2.8 | 3.2 | 1.8 | · | 4.3 |
الكفاءة 3
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | · | · | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | |
| Inventory Turnover | 0.6 | · | · | 0.6 | 0.6 | 0.5 | · | 0.5 | 0.6 | 0.5 | · | 0.6 | 0.6 | 0.5 | · | 0.5 | |
| Receivables Turnover | 12.5 | · | · | 14.2 | 14.1 | 13.7 | · | 15.4 | 15.2 | 14.6 | · | 15.6 | 15.5 | 14.8 | · | 15.2 |
التقييم (آخر 12 شهرًا) 15
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $5.18B | $5.07B | · | $4.99B | $5.00B | $5.01B | · | $5.07B | $5.14B | $5.11B | · | $5.14B | $5.25B | $5.28B | · | $5.45B | |
| Net Income TTM | $128M | $205M | · | $190M | $152M | $127M | · | $119M | $132M | $156M | · | $214M | $258M | $296M | · | $384M | |
| Market Cap | $1.38B | · | · | $871M | $889M | $877M | · | $724M | $1.05B | $1.00B | · | $1.39B | $1.31B | $1.59B | · | $1.95B | |
| Enterprise Value | $3.02B | · | · | $2.58B | $2.71B | $2.74B | · | $2.58B | $3.01B | $3.01B | · | $3.44B | $3.41B | $3.76B | · | $4.17B | |
| P/E | 10.8 | 7.5 | · | 4.6 | 5.8 | 7.0 | · | 6.1 | 7.9 | 6.4 | · | 6.5 | 5.1 | 5.4 | · | 5.3 | |
| P/S | 0.3 | · | · | 0.2 | 0.2 | 0.2 | · | 0.1 | 0.2 | 0.2 | · | 0.3 | 0.2 | 0.3 | · | 0.4 | |
| P/B | -2.9 | · | · | -1.4 | -1.3 | -1.2 | · | -0.8 | -1.0 | -1.0 | · | -1.3 | -1.1 | -1.3 | · | -1.4 | |
| P / Cash Flow | · | · | · | · | · | 4384.0 | · | · | · | 72.7 | · | · | · | 34.4 | · | · | |
| P / FCF | · | · | · | · | · | -48.4 | · | · | · | -52.5 | · | · | · | 99.9 | · | · | |
| EV / EBITDA | 23.6 | · | · | 20.5 | 20.4 | 22.3 | · | 20.3 | 37.5 | 41.9 | · | 32.2 | 27.6 | 53.4 | · | 28.3 | |
| EV / FCF | · | 29.8 | · | · | · | -151.4 | · | · | · | -157.7 | · | · | · | 236.7 | · | · | |
| EV / Revenue | 0.6 | · | · | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.6 | 0.6 | · | 0.7 | 0.6 | 0.7 | · | 0.8 | |
| Dividend Yield | 0.00% | · | · | 0.00% | 0.00% | 0.00% | · | 0.00% | 0.00% | 0.00% | · | 0.00% | 0.00% | 0.00% | · | 0.00% | |
| Earnings Yield | 9.3% | 13.3% | · | 21.9% | 17.2% | 14.4% | · | 16.4% | 12.7% | 15.5% | · | 15.4% | 19.6% | 18.4% | · | 18.9% | |
| Annual Payout | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 |
القوائم المالية قائمة الدخل، الميزانية العمومية، التدفقات النقدية — سنويًا، آخر 5 سنوات
قائمة الدخل
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| الإيرادات | $5.04B | $4.99B | $5.06B | $5.20B | $5.80B |
| هامش الربح الإجمالي % | 77.9% | 77.9% | 76.5% | 77.5% | 78.6% |
| هامش الربح التشغيلي % | 9.6% | 7.7% | 7.0% | 10.5% | 12.7% |
| صافي الدخل | $228M | $254M | $142M | $321M | $447M |
| EPS المخفف | $2.20 | $2.50 | $1.42 | $3.23 | $4.13 |
الميزانية العمومية
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| الدين / حقوق الملكية | -3.9 | -2.8 | -2.4 | -2.1 | -2.0 |
| النسبة الحالية | 1.1 | 0.9 | 1.1 | 1.4 | 1.3 |
| النسبة السريعة | 0.4 | 0.4 | 0.5 | 0.6 | 0.6 |
التدفق النقدي
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| التدفق النقدي الحر | $253M | $163M | $222M | $196M | $309M |
آخر الأخبار أحدث العناوين التي تذكر هذه الشركة
مقاييسي قائمة المراقبة الشخصية الخاصة بك — صفوف مختارة من الأساسيات الكاملة
اختر المقاييس التي تهمك — انقر فوق علامة ➕ بجوار أي صف في الأساسيات الكاملة أعلاه.
يتم حفظ اختيارك ويتبعك عبر جميع الأسهم.
الملاك المؤسسيون (13F) 269 مقدمي إقرار · $1.2B إجمالي · حتى تاريخ 30 يونيو، 2026
المؤسسات التي تبلغ عن حيازتها لهذا السهم في نموذج SEC 13F ربع السنوي الخاص بها. المراكز الطويلة فقط؛ قد يظهر مقدم واحد مرتين لأرجل خيارات منفصلة. الأرجل الكبيرة المتعاكسة من خيارات البيع/الشراء تعكس عادةً صناعة السوق أو المخزون المتحوط، وليس القناعة الاتجاهية.
| مراكز جديدة | المراكز الخارجة | زيادة | انخفض | صافي التغير في الأسهم |
|---|---|---|---|---|
| 41 (-20 مقابل الربع السابق) | 42 (+8 مقابل الربع السابق) | 90 (+9 مقابل الربع السابق) | 73 (-9 مقابل الربع السابق) | +4.1M |
مقارنة بـ Q1 2026. المواعيد النهائية لتقديم إقرارات نموذج 13F لهيئة الأوراق المالية والبورصات (SEC) هي في غضون 45 يومًا من نهاية الربع بالإضافة إلى فترة سماح قصيرة للمقدمين المتأخرين — يتم تخطي الأرباع التي لا تزال ضمن هذه النافذة لصالح أحدث زوج تم الإبلاغ عنه بالكامل.
| مؤسسة | القيمة | الأسهم | % من 13F المتتبعة | النوع |
|---|---|---|---|---|
| Route One Investment Company, L.P. | $109786720 | 8348800 | 9,20% | الأسهم |
| Nantahala Capital Management, LLC | $86790000 | 6600000 | 7,28% | عقد خيار الشراء |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $81428443 | 6192277 | 6,83% | الأسهم |
| RENAISSANCE TECHNOLOGIES LLC | $66074384 | 5024668 | 5,54% | الأسهم |
| VANGUARD CAPITAL MANAGEMENT LLC | $58016485 | 4411900 | 4,86% | الأسهم |
| GEODE CAPITAL MANAGEMENT, LLC | $40514448 | 3080442 | 3,40% | الأسهم |
| Solel Partners LP | $37452712 | 2848115 | 3,14% | الأسهم |
| STATE STREET CORP | $33478164 | 2545868 | 2,81% | الأسهم |
| TWO SIGMA INVESTMENTS, LP | $30743240 | 2337889 | 2,58% | الأسهم |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $29752204 | 2262525 | 2,49% | الأسهم |
| CITADEL ADVISORS LLC | $28811650 | 2191000 | 2,42% | عقد خيار البيع |
| FMR LLC | $27968275 | 2126865 | 2,34% | الأسهم |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $27830844 | 2116414 | 2,33% | الأسهم |
| IRIDIAN ASSET MANAGEMENT LLC/CT | $26671882 | 2028280 | 2,24% | الأسهم |
| Quantedge Capital Pte Ltd | $24273427 | 1845888 | 2,04% | الأسهم |
| DIMENSIONAL FUND ADVISORS LP | $23029135 | 1751265 | 1,93% | الأسهم |
| Long Focus Capital Management, LLC | $22344480 | 1699200 | 1,87% | الأسهم |
| CITIGROUP INC | $18410000 | 1400000 | 1,54% | عقد خيار الشراء |
| CITIGROUP INC | $18089903 | 1375658 | 1,52% | الأسهم |
| VICTORY CAPITAL MANAGEMENT INC | $16357588 | 1243923 | 1,37% | الأسهم |
| Caption Management, LLC | $15780000 | 1200000 | 1,32% | عقد خيار الشراء |
| GOLDMAN SACHS GROUP INC | $15559843 | 1183258 | 1,30% | الأسهم |
| Penn Capital Management Company, LLC | $15069481 | 1145024 | 1,26% | الأسهم |
| Nantahala Capital Management, LLC | $14585375 | 1109154 | 1,22% | الأسهم |
| Tenzing Global Management, LLC | $13150000 | 1000000 | 1,10% | الأسهم |
| TWO SIGMA ADVISERS, LP | $12019925 | 932500 | 1,01% | الأسهم |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $11797786 | 897170 | 0,99% | الأسهم |
| CITADEL ADVISORS LLC | $11022330 | 838200 | 0,92% | عقد خيار الشراء |
| FIRST TRUST ADVISORS LP | $10198574 | 775557 | 0,86% | الأسهم |
| VANGUARD FIDUCIARY TRUST CO | $9024227 | 686253 | 0,76% | الأسهم |
| NEW YORK STATE COMMON RETIREMENT FUND | $8941579 | 679968 | 0,75% | الأسهم |
| Qube Research & Technologies Ltd | $8218487 | 624980 | 0,69% | الأسهم |
| Aristotle Capital Boston, LLC | $7466962 | 567829 | 0,63% | الأسهم |
| PANAGORA ASSET MANAGEMENT INC | $7361817 | 559834 | 0,62% | الأسهم |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $7131245 | 542300 | 0,60% | عقد خيار الشراء |
| MILLENNIUM MANAGEMENT LLC | $6408639 | 487349 | 0,54% | الأسهم |
| Manatuck Hill Partners, LLC | $6039269 | 459260 | 0,51% | الأسهم |
| Squarepoint Ops LLC | $5633144 | 428376 | 0,47% | الأسهم |
| Johnson Financial Group, LLC | $5451859 | 414590 | 0,46% | الأسهم |
| Lombard Odier Asset Management (USA) Corp | $5292875 | 402500 | 0,44% | عقد خيار الشراء |
| Trexquant Investment LP | $5265773 | 400439 | 0,44% | الأسهم |
| ALGERT GLOBAL LLC | $5263550 | 400270 | 0,44% | الأسهم |
| CANTOR FITZGERALD, L. P. | $5167950 | 393000 | 0,43% | عقد خيار الشراء |
| Huber Capital Management LLC | $4841343 | 368163 | 0,41% | الأسهم |
| Balyasny Asset Management L.P. | $4707332 | 357972 | 0,39% | الأسهم |
| General Equity Holdings LP | $4669841 | 355121 | 0,39% | الأسهم |
| CITIGROUP INC | $4602500 | 350000 | 0,39% | عقد خيار البيع |
| Connor, Clark & Lunn Investment Management Ltd. | $4265360 | 324362 | 0,36% | الأسهم |
| BANK OF AMERICA CORP /DE/ | $4261941 | 324102 | 0,36% | الأسهم |
| Bronte Capital Management Pty Ltd. | $4252526 | 323386 | 0,36% | الأسهم |
| Pekin Hardy Strauss, Inc. | $4129021 | 313994 | 0,35% | الأسهم |
| ALLIANCEBERNSTEIN L.P. | $4008933 | 272346 | 0,34% | الأسهم |
| GROUP ONE TRADING LLC | $3990407 | 303453 | 0,33% | الأسهم |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $3951522 | 300496 | 0,33% | الأسهم |
| JANE STREET GROUP, LLC | $3814815 | 290100 | 0,32% | عقد خيار البيع |
| CIBC Private Wealth Group LLC | $3689284 | 437119 | 0,31% | الأسهم |
| STATE OF WISCONSIN INVESTMENT BOARD | $3670152 | 279099 | 0,31% | الأسهم |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $3597840 | 273600 | 0,30% | عقد خيار البيع |
| XTX Topco Ltd | $3362179 | 255679 | 0,28% | الأسهم |
| Quantinno Capital Management LP | $3160550 | 240346 | 0,26% | الأسهم |
| Parallax Volatility Advisers, L.P. | $3130187 | 238037 | 0,26% | الأسهم |
| JANE STREET GROUP, LLC | $3095510 | 235400 | 0,26% | عقد خيار الشراء |
| Caption Management, LLC | $2956778 | 224850 | 0,25% | الأسهم |
| Swiss National Bank | $2729572 | 207572 | 0,23% | الأسهم |
| PICTON MAHONEY ASSET MANAGEMENT | $2714766 | 206446 | 0,23% | الأسهم |
| MAI Capital Management | $2667530 | 202854 | 0,22% | الأسهم |
| Engineers Gate Manager LP | $2662651 | 202483 | 0,22% | الأسهم |
| Vanguard Global Advisers, LLC | $2576874 | 195960 | 0,22% | الأسهم |
| D. E. Shaw & Co., Inc. | $2336321 | 177667 | 0,20% | الأسهم |
| Corient Private Wealth LP | $2330168 | 177199 | 0,20% | الأسهم |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | $2110338 | 160482 | 0,18% | الأسهم |
| Inspire Investing, LLC | $2079597 | 141277 | 0,17% | الأسهم |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $2038105 | 154989 | 0,17% | الأسهم |
| VANGUARD GROUP INC | $1977262 | 153395 | 0,17% | الأسهم |
| Shay Capital LLC | $1972500 | 150000 | 0,17% | عقد خيار الشراء |
| SEGALL BRYANT & HAMILL, LLC | $1820539 | 138444 | 0,15% | الأسهم |
| RHUMBLINE ADVISERS | $1808062 | 137496 | 0,15% | الأسهم |
| Y-Intercept (Hong Kong) Ltd | $1791043 | 136201 | 0,15% | الأسهم |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $1728555 | 117429 | 0,14% | الأسهم |
| Point72 Asset Management, L.P. | $1724951 | 131175 | 0,14% | الأسهم |
| DENALI ADVISORS LLC | $1722650 | 131000 | 0,14% | الأسهم |
| PRINCIPAL FINANCIAL GROUP INC | $1663225 | 126481 | 0,14% | الأسهم |
| Bridgewater Associates, LP | $1524677 | 115945 | 0,13% | الأسهم |
| CITADEL ADVISORS LLC | $1519246 | 115532 | 0,13% | الأسهم |
| AMERIPRISE FINANCIAL INC | $1481571 | 112667 | 0,12% | الأسهم |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $1473000 | 112000 | 0,12% | الأسهم |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $1315000 | 100000 | 0,11% | الأسهم |
| DIVERSIFY WEALTH MANAGEMENT, LLC | $1272311 | 104459 | 0,11% | الأسهم |
| Diversify Advisory Services, LLC | $1272311 | 104459 | 0,11% | الأسهم |
| CenterBook Partners LP | $1223068 | 93009 | 0,10% | الأسهم |
| WOLVERINE ASSET MANAGEMENT LLC | $1223055 | 93008 | 0,10% | الأسهم |
| DGS Capital Management, LLC | $1211795 | 82323 | 0,10% | الأسهم |
| DARK FOREST CAPITAL MANAGEMENT LP | $1167536 | 88786 | 0,10% | الأسهم |
| BlackRock, Inc. | $1143919 | 86990 | 0,10% | الأسهم |
| WOLVERINE TRADING, LLC | $1108853 | 130300 | 0,09% | عقد خيار الشراء |
| TEACHER RETIREMENT SYSTEM OF TEXAS | $1084441 | 82467 | 0,09% | الأسهم |
| Arena Capital Advisors, LLC- CA | $1063967 | 80910 | 0,09% | الأسهم |
| Graham Capital Management, L.P. | $1057221 | 80397 | 0,09% | الأسهم |
| BW Gestao de Investimentos Ltda. | $1052000 | 80000 | 0,09% | الأسهم |
| TWO SIGMA INVESTMENTS, LP | $1046740 | 79600 | 0,09% | عقد خيار البيع |
المطلعون على الشركة 95 من المطلعين · مسؤولون 35 · مديرون 41
| مطلع | الدور | آخر نشاط | الأسهم المملوكة | مشتريات 12 شهرًا | مبيعات 12 شهرًا | صافي 12 شهرًا |
|---|---|---|---|---|---|---|
| Stephan Paulo Gratziani | Chief Executive Officer | 3 مايو، 2026 F | 107310 | 0 | 0 | $0 |
| John O Agwunobi | Chairman and CEO | 10 مايو، 2022 P | 134745 | 0 | 0 | $0 |
| Richard Goudis | Chief Executive Officer | 17 سبتمبر، 2018 M | 861213 | 0 | 0 | $0 |
| John Desimone | Chief Financial Officer | 25 فبراير، 2026 A | 241144 | 0 | 0 | $0 |
| Alexander Amezquita | Chief Financial Officer | 3 مارس، 2024 F | 152042 | 0 | 0 | $0 |
| Robert Levy | President | 4 مايو، 2026 F | 11405 | 0 | 0 | $0 |
| Gregory Probert | President & COO | 4 إبريل، 2008 A | 158086 | 0 | 0 | $0 |
| Brian Kane | President - Europe | 14 أكتوبر، 2005 M | 651442 | 0 | 0 | $0 |
| Troy Hicks | Chief Operating Officer | 18 مايو، 2026 M | 9706 | 0 | 2 | $-619415 |
| Mark J Schissel | Chief Operating Officer | 7 إبريل، 2023 F | 185090 | 0 | 0 | $0 |
| David Pezzullo | Chief Operating Officer | 26 فبراير، 2021 F | 170316 | 0 | 0 | $0 |
| Jehangir D Irani | SVP, Chief Accounting Officer | 4 مايو، 2026 F | 46371 | 0 | 0 | $0 |
| Henry C Wang | Chief Legal Officer | 4 مايو، 2026 F | 142514 | 0 | 0 | $0 |
| Ibelis Montesino | EVP & Chief of Staff | 3 مايو، 2024 A | 160812 | 0 | 0 | $0 |
| Stephen Conchie | Regional Pres. APAC & China | 4 مايو، 2023 A | 81793 | 0 | 0 | $0 |
| Edi Hienrich | Regional Pres. EMEA & India | 4 مايو، 2023 A | 34361 | 0 | 0 | $0 |
| Alan L Hoffman | EVP, Global Corporate Affairs | 17 مايو، 2022 P | 57218 | 0 | 0 | $0 |
| Thomas Harms | SVP, China & APAC | 26 فبراير، 2021 F | 30509 | 0 | 0 | $0 |
| Jesus Alzarez | VP, General Manager, Mexico | 9 مارس، 2018 S | 2085 | 0 | 0 | $0 |
| Jossie Aspauza | VP, SAM/CAM | 5 مارس، 2018 M | 6546 | 0 | 0 | $0 |
| Calero Miguel Angel Fernandez | EVP, The Americas & WWD Ops | 12 مايو، 2017 S | 0 | 0 | 0 | $0 |
| Jerry Li | SVP, Managing Director, China | 11 مايو، 2017 S | 0 | 0 | 0 | $0 |
| Gioji Okuhara | VP, General Manager, Brazil | 23 فبراير، 2017 A | — | 0 | 0 | $0 |
| Mark J Friedman | General Counsel | 23 فبراير، 2017 A | 3916 | 0 | 0 | $0 |
| William Rahn | SVP / Mg Dir. - Asia Pacific | 11 فبراير، 2015 A | 0 | 0 | 0 | $0 |
| Brett Chapman | Chief Legal Officer | 12 أغسطس، 2014 P | 300 | 0 | 0 | $0 |
| Patricio Cuesta | SVP/Managing Director SAM | 22 يوليو، 2014 M | 8643 | 0 | 0 | $0 |
| Thomas Zimmer | SVP, North America | 30 نوفمبر، 2010 A | 11935 | 0 | 0 | $0 |
| Yair Steve Henig | Chief Scientific Officer | 1 أكتوبر، 2010 M | 9776 | 0 | 0 | $0 |
| David Wynne Roberts | SVP - EMEA | 29 يوليو، 2009 A | 14829 | 0 | 0 | $0 |
| Mora Adriana Gabriela Mendizabal | SVP - Mexico & Central America | 2 إبريل، 2009 A | 19175 | 0 | 0 | $0 |
| Eneida Bini | Senior Vice President, Brazil | 31 مارس، 2008 M | 1437 | 0 | 0 | $0 |
| Percy Chin | SVP, Greater China | 29 مايو، 2007 A | 3265 | 0 | 0 | $0 |
| Sergio Medina Gomez | SVP, Mexico & Central America | 24 مايو، 2007 M | 416 | 0 | 0 | $0 |
| John Purdy | Regional Director Asia Pacific | 8 مايو، 2006 M | 56200 | 0 | 0 | $0 |
| Sophie L'Helias | مدير | 4 يونيو، 2026 P | 79882 | 3 | 0 | $29020 |
| Rodica Macadrai | مدير | 8 مايو، 2026 A | 67441 | 0 | 0 | $0 |
| Perkins Miller | مدير | 8 مايو، 2026 A | 50769 | 0 | 0 | $0 |
| Juan Miguel Mendoza | مدير | 8 مايو، 2026 A | 181879 | 0 | 0 | $0 |
| Lynda Cloud | مدير | 8 مايو، 2026 A | 50736 | 1 | 0 | $152490 |
| Maria Otero | مدير | 8 مايو، 2026 A | 95129 | 0 | 0 | $0 |
| Donal Mulligan | مدير | 8 مايو، 2026 A | 68982 | 0 | 0 | $0 |
| Richard H Carmona | مدير | 8 مايو، 2026 A | 83645 | 0 | 0 | $0 |
| Des Walsh | مدير | 8 مايو، 2026 A | 61879 | 0 | 0 | $0 |
| Michael J Levitt | مدير | 8 مايو، 2026 A | 49393 | 0 | 0 | $0 |
| Michael Johnson | مدير | 25 فبراير، 2026 A | 887415 | 0 | 0 | $0 |
| Celine Del Genes | مدير | 2 مايو، 2025 A | 55818 | 0 | 0 | $0 |
| Alan W Lefevre | مدير | 3 مايو، 2024 A | 69117 | 0 | 0 | $0 |
| Kevin M. Jones | مدير | 4 مايو، 2023 A | 19589 | 0 | 0 | $0 |
| John Tartol | مدير | 9 ديسمبر، 2022 P | 321793 | 0 | 0 | $0 |
المطلعون من إيداعات SEC Form 3/4/5؛ صافي = سوق مفتوح فقط
الناشطون والمالكون بنسبة 5%+ 23 حيازة
المستثمرون الذين قدموا الجدول الزمني 13D لدى هيئة الأوراق المالية والبورصات — ملكية مستفيدة تزيد عن 5% مع نية التأثير على المُصدر (حصص الناشطين، حملات مجلس الإدارة، الاندماج والاستحواذ). يعرض كل صف أحدث حالة معروفة لمركز مقدم الطلب هذا.
| مقدم | مقدم | حصة | الحالة | الغرض | إيداع |
|---|---|---|---|---|---|
| Icahn Partners Master Fund LP, Icahn Offshore LP, Icahn Partners LP, Icahn Onshore LP, Icahn Capital LP, IPH GP LLC, Icahn Enterprises Holdings L.P., Icahn Enterprises G.P. Inc., Beckton Corp., Carl C. Icahn ×3 إيداعات | 6 مايو، 2021 | — | إيداع أولي | — | SEC |
| 5 نوفمبر، 2020 | — | إيداع أولي | — | SEC | |
| 12 أغسطس، 2020 | — | إيداع أولي | — | SEC | |
| High River Limited Partnership, Hopper Investments LLC, Barberry Corp., Icahn Partners Master Fund LP, Icahn Offshore LP, Icahn Partners LP, Icahn Onshore LP, Icahn Capital LP, IPH GP LLC, Icahn Enterprises Holdings L.P., Icahn Enterprises G.P. Inc., Beckton Corp., Carl C. Icahn ×14 إيداعات | 30 أكتوبر، 2019 | — | إيداع أولي | — | SEC |
| 25 مايو، 2018 | — | إيداع أولي | — | SEC | |
| 20 مارس، 2018 | — | إيداع أولي | — | SEC | |
| 21 أغسطس، 2017 | — | إيداع أولي | — | SEC | |
| 24 مارس، 2014 | — | إيداع أولي | — | SEC | |
| 14 مارس، 2014 | — | إيداع أولي | — | SEC | |
| William P. Stiritz ×2 إيداعات | 30 يناير، 2014 | — | إيداع أولي | الهيكل الرأسمالي | SEC |
| Whitney V, L.P., Whitney Strategic Partners V, L.P., Whitney Equity Partners V, LLC ×4 إيداعات | 4 مايو، 2007 | — | إيداع أولي | — | SEC |
| 19 إبريل، 2007 | — | إيداع أولي | — | SEC | |
| 19 إبريل، 2007 | — | إيداع أولي | — | SEC | |
| 9 إبريل، 2007 | — | إيداع أولي | — | SEC | |
| 9 إبريل، 2007 | — | إيداع أولي | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ملكية صناديق المؤشرات المتداولة محتفظ بها بواسطة 32 صناديق مؤشرات متداولة
الوزن يعكس فقط ممتلكات الأسهم المباشرة (N-PORT)؛ قد تحتفظ الصناديق المضاعفة أو القائمة على المشتقات بتعرض إضافي للمقايضة غير معروض.
| صندوق | الوزن | الوحدات | حتى تاريخ | المصدر |
|---|---|---|---|---|
| RSSL · Global X Funds | 0,05% | 44299 NS | 30 إبريل، 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,04% | 335706 NS | 30 إبريل، 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,01% | 12198 NS | 30 إبريل، 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,01% | 15531 NS | 30 إبريل، 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 3790 NS | 31 مايو، 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,01% | 155112 NS | 30 إبريل، 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 25109 NS | 30 إبريل، 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 42325 NS | 30 إبريل، 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 665 NS | 30 إبريل، 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | — | — | 15 يوليو، 2026 | يومي |
| VB · VANGUARD INDEX FUNDS | — | — | 15 يوليو، 2026 | يومي |
| VBR · VANGUARD INDEX FUNDS | — | — | 15 يوليو، 2026 | يومي |
| VTI · VANGUARD INDEX FUNDS | — | — | 15 يوليو، 2026 | يومي |
| VFMO · VANGUARD WELLINGTON FUND | — | — | 30 يوليو، 2026 | يومي |
| VFVA · VANGUARD WELLINGTON FUND | — | — | 30 يوليو، 2026 | يومي |
| VTWO · VANGUARD SCOTTSDALE FUNDS | — | — | 15 يوليو، 2026 | يومي |
| VTWV · VANGUARD SCOTTSDALE FUNDS | — | — | 15 يوليو، 2026 | يومي |
| VTWG · VANGUARD SCOTTSDALE FUNDS | — | — | 15 يوليو، 2026 | يومي |
| VTHR · VANGUARD SCOTTSDALE FUNDS | — | — | 15 يوليو، 2026 | يومي |
| ITOT · iShares Trust | — | — | 22 يوليو، 2026 | يومي |
| IWV · iShares Trust | — | — | 18 أغسطس، 2026 | يومي |
| IWN · iShares Trust | — | — | 17 أغسطس، 2026 | يومي |
| IWO · iShares Trust | — | — | 18 أغسطس، 2026 | يومي |
| IWM · iShares Trust | — | — | 18 أغسطس، 2026 | يومي |
| PBJ · Invesco Exchange-Traded Fund Trust | — | — | 13 أغسطس، 2026 | يومي |
| PRFZ · Invesco Exchange-Traded Fund Trust | — | — | 23 يوليو، 2026 | يومي |
| NEAR · iShares U.S. ETF Trust | — | — | 18 أغسطس، 2026 | يومي |
| VDC · VANGUARD WORLD FUND | — | — | 20 يوليو، 2026 | يومي |
| ISCB · iShares Trust | — | — | 20 يوليو، 2026 | يومي |
| ISCV · iShares Trust | — | — | 20 يوليو، 2026 | يومي |
| SMLF · iShares Trust | — | — | 10 أغسطس، 2026 | يومي |
| WSML · iShares Trust | — | — | 20 يوليو، 2026 | يومي |